2,3,5-Tri-O-benzoyl-2'-C-Methyl-D-Ribonic Acid-1,4-Lactone

7392-74-7

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-ori ented and realizes industrial development through R&amΩp;D innovation and technology transformation.

key word:

technology Pharmaceutical

Category:

Consulting
Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to b₩uild a large health industry finance platform company integrating pharmaceutical,α intelligent medical, bio pharmaceutical R&D, industrial produc​tion and sales.

The chemical reactions involved in the existing products incl ude Foucault reaction, nitration reaction, sulfonation reaction, hydrogenatiδon reaction, fluorination reaction, chlorination rea∑ction, bromination reaction, diazotization reaction, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed by ¶Merck. In October 2006, Sitagliptin phosphate Januvia was approved by FDA as the fi✘rst DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. The charact✔eristics of this drug are that it can stimulate insulin secretion while reduci ng hunger without causing weight gain. Hypoglycemia and  edema will not occur, and it is suitable for diabetic patients with poor blood gluc≠ose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical∑ enterprise that is market-oriented and realizes industrial development through R∏&D innovation and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important products for' the treatment of arthritis. It is well tolerated and has a low incidence of side efαfects

Pranlukast

Pranlukast, developed by Ono, is one of the three major€ leukotriene receptor antagonists. In clinical application, it has goo÷d therapeutic effect on atopic asthma and other types of b$ronchial asthma, and the market prospect is huge. In‌ the major category of asthma drugs, leukotriene receptor antagonists have ∑the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is mark₩et-oriented and realizes industrial development through R&D innovation and tech™nology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved by FDA forα Alzheimer's disease in the United States. Its treatment ↓reaches the target dose and has low toxic and side effects. It has been widely recogni♦zed by our medical community, and good tolerance is its biggest advantage. In October 1999, Do↕nepezil was launched in China under the trade name "Aricept"•, which is the main chemical drug against Alzheimer's disease. A←t present, CFDA has approved a number of domestic enterpriseΩs to produce donepezil preparations, the main dosage forms are tablets, capsules, dispersive &tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliqu"is, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was© approved for use in the 27 EU member states. The world's first drug approved δto prevent venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replaceme¥nt. From June 2019 to June 2020, the annual sales of apixaban products overseas reached ≤about $15.4 billion, with a year-on-year growth of nearly 32%, and the API consumption reacγhed about 23,960 kg, with a year-on-year growth of about 28%. Compared with÷ its main competitor, Rivaroxaban, the drug's annual overseas sales are about $4.5 billion ‌higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise th₽at is market-oriented and realizes industrial development through R&D innovatio≈n and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvisi☆on and manufactured by Genzyme. On December 29, 2004, it was approveβd by FDA for the treatment of refractory or relapsed acute lymphoblastπic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutica¥l enterprise that is market-oriented and realizes industrial development through R&D innovationπ and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working da♣ys). If you need other services, E-mail: 2880705932@qq.com